 |
|
|
| |
Effectiveness of Elbasvir/Grazoprevir in Patients with Cirrhotic Genotype
1 or 4 Chronic Hepatitis C: Updated Retrospective Data Analyses from the TRIO Network
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
MICHAEL CURRY1, STEVENFLAMM2, BRUCEBACON3 , SCOTT MILLIGAN4, CHIZOBANWANKWO5, NAOKYTSAI6,, NICOLE WICK4, ZOBAIR YOUNOSSI7AND NEZAM AFDHAL1
1Beth Israel Deaconess Medical Center, 2Northwestern University Medical School, 3Saint Louis University School of Medicine, 4Trio Health Analytics, 5Merck & Co., Inc., Kenilworth, NJ, USA,
6University of Hawaii; Queens Medical Center, 7Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital
|
| |
|
|
|
|
|
